insights_auto
Varför har CRL gått upp 7,09%?
Gå på djupetchevron_right
CRL:NYSE
Charles River Laboratories Intrtnl, Inc.
310,77 US$
arrow_upward
+7,09%(+20,58) 1 d
310,77 US$
0,00% (0,00)
bedtimeEfter stängning
Stängd: 5 okt., 16:00:07 GMT−4 · USD
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för CRL …
Öppen
292,05 US$
Högt
312,26 US$
Lågt
292,02 US$
Börsvärde
14,84 md
Genomsn. vol.
920,10 tn
Volym
0,00
52v högst
312,26 US$
52v lägst
146,20 US$
EPS
−4,85 US$
Beta
1,40
Utestående aktier
47,74 mn
Antal anställda
19 tn
Öppen
292,05 US$
Högt
312,26 US$
Lågt
292,02 US$
Börsvärde
14,84 md
Genomsn. vol.
920,10 tn
Volym
0,00
52v högst
312,26 US$
52v lägst
146,20 US$
EPS
−4,85 US$
Beta
1,40
Utestående aktier
47,74 mn
Antal anställda
19 tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
MarketWatch
·
för 11 timmar sedan
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
TradingKey
·
för 11 timmar sedan
Charles River Laboratories International Inc Stock (CRL) Closed Up by 7.09% on Oct 5: Key Drivers Unveiled
Investing.com UK
·
för 15 timmar sedan
Charles River Laboratories stock hits 52-week high at 303.33 USD
Profil
Charles River Laboratories International, Incorporated is an American life sciences company and contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides goods and services that support the development of drugs, vaccines, and other therapeutics. Its operations span at least 20 countries, offering research models, drug discovery and safety assessment, and manufacturing and testing services to pharmaceutical, biotechnology, government, and other clients.
Charles River Laboratories is a global provider of non-clinical drug development services, known for its role in toxicology studies, research animal models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of research animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Om Charles River Laboratories Intrtnl, Inc.